在EudraVigilance:比较研究和性别分布中涉嫌与白素-23抑制剂相关的瘤不良反应:比较研究和性别分布
Fabrizio Calapai1,2, Carmen Mannucci3, Luigi Cardia4
1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Pharmacology research & perspectives
|August 24, 2023
概括
皮病治疗的向Interleukin (IL) -23的治疗方法,特别是risankizumab和tildrakizumab,可能与癌症风险有关. 现实世界的数据表明,这种联系在男性中比女性更为普遍.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药物监督 药物监督 药物监督
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,与癌症风险增加有关.
- 干白素 (IL) -23通过Th17通路在牛皮病原发生过程中起着关键作用.
- IL-23抑制剂是有效的牛皮治疗方法,但其致癌潜力尚不清楚.
研究的目的:
- 研究IL-23抑制剂与恶性瘤之间的潜在关联.
- 分析使用IL-23抑制剂的牛皮患者癌症疑似不良反应 (SARs) 的现实数据.
主要方法:
- 利用来自欧洲EudraVigilance数据库的现实数据.
- 在接受IL-23抑制剂 (guselkumab,tildrakizumab,risankizumab) 治疗的患者中分析了恶性瘤的SAR.
主要成果:
- 现实世界的数据表明,在牛皮患者中,瑞桑基祖马布,蒂尔德拉基祖马布和与癌症相关的SARS之间存在潜在的关联.
- 观察到IL-23抑制剂和癌症SARs之间的关联显示出性别差异,男性患病率更高.
结论:
- IL-23抑制剂,特别是瑞桑基祖马布和蒂尔德拉基祖马布,可能与牛皮患者恶性瘤风险的增加有关.
- 需要进一步的研究来证实这些发现,并了解与IL-23抑制剂相关的癌症风险的性别特异差异.
关键词:
一个IL-23抑制剂.不良反应是不良反应.癌症 癌症 癌症 癌症 癌症这就是Guselkumabb.药物监督和药物监督牛皮是一种牛皮.现实世界的真实世界.他们的风险是kizumabb.这就是Tildrakizumab.更多相关视频
相关概念视频
Pharmacovigilance
889
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
889
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
242
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
242
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Allergic Drug Reactions
875
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
875

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
